
IFF Stock Forecast & Price Target
IFF Analyst Ratings
Bulls say
International Flavors & Fragrances (IFF) has demonstrated a solid financial performance, with net sales reaching $2,771 million in the most recent quarter, reflecting a year-over-year increase of 3% and a more significant 6% growth when excluding foreign exchange impacts. The company has shown consistent volume growth, accelerating for the fifth consecutive quarter with high single-digit increases across all business segments, particularly in Functional Ingredients. Additionally, the company anticipates organic sales growth of 1-4% for FY25, driven by positive trends across all segments, indicating a strong outlook for continued financial strength and stability.
Bears say
International Flavors & Fragrances faces several downside risks that adversely impact its financial outlook, including macroeconomic weakness which may dampen customer demand, competitive pressures, rising input costs, and unfavorable foreign exchange fluctuations that have led to higher-than-expected EBITDA shortfalls. The anticipated sale of the Pharma segment, while aimed at reducing leverage to approximately 3x by year-end 2025, reflects the company's endeavor to address recent financial challenges amidst declining sales and earnings per share (EPS) projections for 2025-2026. Additionally, the recent 5.2% decline in stock value, alongside adjustments to earnings estimates, underscores the negative sentiment and the need for strategic realignment in a competitive and volatile economic environment.
This aggregate rating is based on analysts' research of International Flavors & Fragrances and is not a guaranteed prediction by Public.com or investment advice.
IFF Analyst Forecast & Price Prediction
Start investing in IFF
Order type
Buy in
Order amount
Est. shares
0 shares